The World of Health & Medicine News

WHO hosts the second Global Summit to advance evidence, integration and innovation for traditional medicine

WHO hosts the second Global Summit to advance evidence, integration and innovation for traditional medicine

The World Health Organization (WHO)’s Second Global Summit on Traditional Medicine, jointly organized with the Government of India, opens today, bringing together government ministers, scientists, Indigenous leaders, and practitioners from more than 100 countries. The Summit is expected to announce major scientific initiatives and new commitments aimed at advancing the implementation of the WHO Global Traditional Medicine Strategy 2025–2034, centred on stronger evidence, better regulation, systems integration, collaboration and community engagement.

Traditional medicine (TM) encompasses codified and non-codified systems that predate biomedicine and have continued to evolve for contemporary use. For many, TM remains the main source of health care—locally accessible, affordable and bio-culturally aligned—and for many more, it is a preferred, personalized and more natural health option. Nearly 90% of WHO Member States (170 out of 194) report that 40–90% of their populations use TM.

“WHO is committed to uniting the wisdom of millennia with the power of modern science and technology to realise the vision of health for all,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “By engaging responsibly, ethically, and equitably, and by harnessing innovation from AI to genomics, we can unlock the potential of traditional medicine to deliver safer, smarter, and more sustainable health solutions for every community and for our planet.”

In a world facing increasing challenges to health systems, nearly half of the global population – 4.6 billion – lack access to essential health services, while a quarter – over 2 billion people –  experience financial hardship to access health care. Integrating TM into health systems is critical to expanding access and choice to affordable, people-centred health care and advancing UHC, ensuring everyone can receive health care they need without financial strain.

Emerging evidence indicates that integrating TM into health systems can deliver cost efficiencies and improve health outcomes. Such integration emphasizes prevention and health promotion, contributing to broader health benefits such as more appropriate use of antibiotics.

Achieving effective integration requires robust science, global standards for quality and safety, and strong regulatory mechanisms. “We need to apply the same scientific rigour to the assessment and validation of biomedicine and traditional medicines, while respecting biodiversity, cultural specificities and ethical principles,” said Dr Sylvie Briand, WHO Chief Scientist. “Stronger collaborations and frontier technologies – such as AI, genomics, systems biology, neurosciences and advanced data analytics – can transform how we study and apply traditional medicine.”

spot_img

Explore more

spot_img

Novo Nordisk wins US approval for weight-loss pill

Novo Nordisk wins US approval for weight-loss pill The U.S. Food and Drug Administration approved Novo Nordisk's weight-loss pill on Monday, giving ​the Danish drugmaker...

Takeda’s AI-crafted psoriasis pill succeeds in late-stage studies

Takeda's AI-crafted psoriasis pill succeeds in late-stage studies Japan's Takeda Pharmaceutical (4502.T), opens new tab said on Thursday its experimental pill for a type of skin disease,...

US FDA approves Cytokinetics’ heart disease drug

US FDA approves Cytokinetics' heart disease drug The U.S. Food and Drug ​Administration has approved ‌Cytokinetics' drug to treat a ‌rare heart condition, the company...

GSK wins US approval for twice-yearly asthma drug

GSK wins US approval for twice-yearly asthma drug  The U.S. health regulator has approved GSK's (GSK.L), opens new tab add-on treatment for severe asthma, offering a less...

US CDC ends guidance that all newborns should get hepatitis B...

US CDC ends guidance that all newborns should get hepatitis B vaccine, in major policy shift The U.S. Centers for Disease Control and Prevention on...

FDA Approves J&J’s Akeega for Expanded Use in Prostate Cancer

FDA Approves J&J's Akeega for Expanded Use in Prostate Cancer Johnson & Johnson JNJ announced that the FDA approved its precision therapy, Akeega (niraparib and abiraterone acetate...

Women are increasingly using steroids — despite these 7 major risks

Women are increasingly using steroids — despite these 7 major risks As fitfluencers push powerlifting, weight training and “whatever it takes” to get toned, more women...

Kyverna’s cell therapy helps patients improve mobility in mid-stage trial

Kyverna's cell therapy helps patients improve mobility in mid-stage trial Kyverna Therapeutics said its experimental cell therapy met the main goal of “significantly” improving patients’...